China's Premier Takes Aim at AI ‘Monopoly' as US Effort Quickens
Artificial intelligence harbors risks from widespread job losses to economic upheaval that require nations to work together to address, Premier Li Qiang told the World Artificial Intelligence Conference in Shanghai on Saturday. That means more international exchanges, Beijing's No. 2 official said during China's most important annual technology summit.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
JD.com, Inc.'s (NASDAQ:JD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
It is hard to get excited after looking at (NASDAQ:JD) recent performance, when its stock has declined 2.2% over the past week. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. In this article, we decided to focus on ROE. Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In short, ROE shows the profit each dollar generates with respect to its shareholder investments. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. How Is ROE Calculated? Return on equity can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for is: 16% = CN¥49b ÷ CN¥309b (Based on the trailing twelve months to March 2025). The 'return' is the profit over the last twelve months. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.16. Check out our latest analysis for Why Is ROE Important For Earnings Growth? We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes. Earnings Growth And 16% ROE At first glance, seems to have a decent ROE. Even when compared to the industry average of 16% the company's ROE looks quite decent. Consequently, this likely laid the ground for the decent growth of 8.6% seen over the past five years by Next, on comparing with the industry net income growth, we found that reported growth was lower than the industry growth of 12% over the last few years, which is not something we like to see. The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. If you're wondering about valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry. Is Making Efficient Use Of Its Profits? has a healthy combination of a moderate three-year median payout ratio of 31% (or a retention ratio of 69%) and a respectable amount of growth in earnings as we saw above, meaning that the company has been making efficient use of its profits. While has been growing its earnings, it only recently started to pay dividends which likely means that the company decided to impress new and existing shareholders with a dividend. Upon studying the latest analysts' consensus data, we found that the company's future payout ratio is expected to drop to 22% over the next three years. However, the company's ROE is not expected to change by much despite the lower expected payout ratio. Summary Overall, we are quite pleased with performance. Specifically, we like that the company is reinvesting a huge chunk of its profits at a high rate of return. This of course has caused the company to see a good amount of growth in its earnings. With that said, the latest industry analyst forecasts reveal that the company's earnings growth is expected to slow down. Are these analysts expectations based on the broad expectations for the industry, or on the company's fundamentals? Click here to be taken to our analyst's forecasts page for the company. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
an hour ago
- Yahoo
Human Babies Aren't Supposed to Have 3 Parents—but Now They Can
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Here's what you'll learn when you read this story: The first babies with three biological parents were born out of a new technique to prevent mitochondrial disease. The nucleus of an egg fertilized in vitro was transferred into a donor egg without a nucleus, but with viable mitochondria. Eight healthy babies, including a set of twins, were born with low to undetectable levels of mitochondrial mutations. The only creatures known to conceive offspring from more than two parents are salamanders. Females from the genus Ambystoma (which are notoriously promiscuous) mate with up to three different males, and that DNA is then incorporated into what is known as a triploid genome in their offspring. Now a version of this has become possible in humans. It seems limb regeneration isn't the only way medical intervention can put humans on salamanders' level. Being born with three genomes is not a phenomenon that occurs naturally in Homo sapiens, but in an attempt to prevent certain genetic conditions caused by mutations in the mitochondria, scientists have found a way. Mitochondrial DNA or mtDNA is exclusively passed down from the maternal side. Dysfunction in the mitochondria can lead to metabolic diseases characterized by symptoms such as seizures, developmental delays, blindness, and loss of muscular function. Some can even be fatal. Mitochondrial diseases occur in about 1 in every 5,000 people. They were previously only preventable by using a donor egg or foregoing the conception of biological children altogether. This is why pediatric neurologist Bobby McFarland, of Newcastle University in the UK, led an experimental study that would reduce and potentially eliminate the risk of mitochondrial disease with a new method of in vitro fertilization. McFarland and his research team wanted see if removing the nucleus of an egg and placing it in a donor egg with viable mitochondria would result in healthy offspring. 'We found that pronuclear transfer, a form of mitochondrial donation, was effective in reducing the level of pathogenic mtDNA variant to substantially below the threshold for clinical disease in the offspring of women with homoplasmic (or high heteroplasmic) levels,' he said in a study recently published in the New England Journal of Medicine. When mitochondria are homoplasmic, all copies produced by cell division have mutations. Mutation levels vary in heteroplasmic mitochondria. Preimplantation genetic testing (PGT) can screen for these abonormalities, and women with homoplasmy or high levels of heteroplasmy can benefit from what is now known as pronuclear transfer. This involves eggs from both the mother and donor being fertilized with the father's sperm in vitro. Nuclei are then removed from both eggs after ten hours. Since the nucleus carries most genetic material and has no connection to mitochondrial disease, the mother's nucleus is implanted into the donor egg to take advantage of its mitochondria. While there is a chance that a few of the mother's mitochondria may end up in the embryo, it is unlikely to cause a debilitating disease. Levels of defective mitochondria in offspring conceived via pronuclear transfer were low enough to escape that fate. Eight pregnancies (including a set of twins) resulted from the experiment, and while there were a few minor health problems in the newborns, these were either treatable or corrected themselves. Not only were levels of heteroplasty low for the babies, but undetectable in five of them. Developmental progress also turned out to be normal. Though one baby had a form of infant epilepsy, and another had heart arrhythmia and hyperlipidemia, or high levels of fats and lipids in the blood, both of these conditions were treated and resolved. Whether the hyperlipidemia was even caused by mtDNA is uncertain, especially because the mother also had severe hyperlipidemia during her pregnancy. Though there was a chance that any of the mothers with pathogenic mtDNA had a higher risk of complications during pregnancy, which could possibly cause their children to have health issues, there is no proof for now. 'We are assessing, over the long term, the health and extent of heteroplasmy (if detectable) of the offspring,' McFarland and his team said. 'Indeed, the role of mitochondrial donation as a choice for women with a heritable pathogenic mtDNA variant will only be established with the availability of additional data.' You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50 Solve the daily Crossword
Yahoo
an hour ago
- Yahoo
An Amazon seller who earns seven figures is starting to make her product in the US due to tariffs. It'll cost more, but it's worth it after 'many sleepless nights.'
Lisa Harrington is shifting 80% of her product catalog to a US-based manufacturer. The move is a response to Trump's tariffs on goods from China. It'll cost her more to produce in the States, but she says it's worth it for the peace of mind. As a full-time Amazon seller, Lisa Harrington relies heavily on her manufacturer. "They can make or break your business in terms of really producing something that's high quality," the founder of Purrfect Portal told Business Insider. Harrington, who started selling dog harnesses and, eventually, interior cat doors, found her first manufacturer through Alibaba, a popular online platform for sourcing products. She worked with them for about four years before pivoting to a different factory in China that her mentor referred her to. That switch happened nearly 10 years ago, and she wasn't planning to make any changes to her supply chain — until President Donald Trump announced tariffs on all imports from China to the US in early 2025. Moving 80% of her catalog to a US-based manufacturer Trump's flip-flopping on tariffs has left business owners feeling uncertain and vulnerable. "I've honestly just had so many sleepless nights over the tariffs," said Harrington, "I've been doing this for 10 years. I've never been in a scenario where my cost of goods could double overnight or triple overnight, and I just couldn't handle that stress anymore." The only solution to alleviate her stress was to onshore a number of her products. "Starting in October, 80% of our catalog is going to be made in the USA," she said, adding that the move "was not on my bingo card, but things are changing quickly." Producing in the States — specifically, in a factory she found in Rhode Island — is "definitely going to cost more," she said. But, it's peace of mind she's after. "Not having to obsessively look at Truth Social or The Wall Street Journal to see what's happening overnight with my business costs, it's just worth it." Harrington, who is a member of various e-comm networks, including the exclusive Million Dollar Sellers community, says most business owners she's spoken to don't have the option of switching manufacturers. "I'm one of the few people who can actually onshore," she said. "There are just so many people I know who can't. They just can't because the numbers just still don't make any sense." Transitioning to a new manufacturer is expensive and time-consuming. E-commerce entrepreneur Shan Shan Fu, who sells over 100 products on Amazon in the women's clothing and accessory space, told BI in May that switching suppliers isn't feasible for her. "The 100 products come from all different factories, so to change and have another factory in, say, Vietnam, replicate what many, many factories are already making, and making it at the same quality and level, is going to take years and years and years, and it would cost more money," she said. She added that most factories require a minimum order quantity: "So they'll say, 'We can't custom-make anything for you unless you order 2,000 pieces.' But if you're a small business, often you can't buy 2,000 pieces right away; you might buy 200, then 500, then 1,000, and you scale up slowly." For many small businesses, suddenly having to place a large order with new suppliers "just isn't doable," she said. "So, we don't have a lot of flexibility to leave China." Harrington, whose closable, plastic cat doors bring in seven figures in annual revenue, said she feels extremely lucky that the economics are working out for her. "I suspect it's because it's plastic. I suspect it's because I have good margins. I suspect it's because I found a really good factory. I feel like a lot of things aligned to make it possible for me to move over," she said. "But I don't know another single person who's doing this because either they can't find a factory or they've gotten prices from American factories, and it's still much more expensive to make it here than it is to deal with the tariffs." Read the original article on Business Insider Sign in to access your portfolio
